Search Results - "Runyon, Scott P."

Refine Results
  1. 1

    Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery by Narayanan, Sanju, Harris, Danni L, Maitra, Rangan, Runyon, Scott P

    Published in Journal of medicinal chemistry (22-10-2015)
    “…Apelin peptides and the apelin receptor represent a relatively new therapeutic axis for the potential treatment of cardiovascular disease. Several reports…”
    Get full text
    Journal Article
  2. 2

    The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor by Perrey, David A., Decker, Ann M., Li, Jun-Xu, Gilmour, Brian P., Thomas, Brian F., Harris, Danni L., Runyon, Scott P., Zhang, Yanan

    Published in Bioorganic & medicinal chemistry (01-09-2015)
    “…[Display omitted] Selective antagonism of the orexin 1 (OX1) receptor has been proposed as a potential mechanism for treatment of drug addiction. We have…”
    Get full text
    Journal Article
  3. 3

    Effect of 1‑Substitution on Tetrahydroisoquinolines as Selective Antagonists for the Orexin‑1 Receptor by Perrey, David A, German, Nadezhda A, Decker, Ann M, Thorn, David, Li, Jun-Xu, Gilmour, Brian P, Thomas, Brian F, Harris, Danni L, Runyon, Scott P, Zhang, Yanan

    Published in ACS chemical neuroscience (15-04-2015)
    “…Selective blockade of the orexin-1 receptor (OX1) has been suggested as a potential approach to drug addiction therapy because of its role in modulating the…”
    Get full text
    Journal Article
  4. 4

    Identification of potent pyrazole based APELIN receptor (APJ) agonists by Narayanan, Sanju, Vasukuttan, Vineetha, Rajagopal, Sudarshan, Maitra, Rangan, Runyon, Scott P.

    Published in Bioorganic & medicinal chemistry (15-02-2020)
    “…[Display omitted] The apelinergic system comprises the apelin receptor and its cognate apelin and elabela peptide ligands of various lengths. This system has…”
    Get full text
    Journal Article
  5. 5

    Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin receptor by Narayanan, Sanju, Dai, Donghua, Vyas Devambatla, Ravi Kumar, Albert, Vincent, Bruneau-Latour, Nicolas, Vasukuttan, Vineetha, Ciblat, Stephane, Rehder, Kenneth, Runyon, Scott P., Maitra, Rangan

    Published in Bioorganic & medicinal chemistry (15-07-2022)
    “…[Display omitted] The apelin receptor (APJ) is a target for cardiovascular indications. Previously, we had identified a novel pyrazole-based agonist 1…”
    Get full text
    Journal Article
  6. 6

    Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice by Narayanan, Sanju, Wang, Shaobin, Vasukuttan, Vineetha, Vyas Devambatla, Ravi Kumar, Dai, Donghua, Jin, Chunyang, Snyder, Rodney, Laudermilk, Lucas, Runyon, Scott P, Maitra, Rangan

    Published in Journal of medicinal chemistry (25-03-2021)
    “…Apelin receptor agonism improves symptoms of metabolic syndrome. However, endogenous apelin peptides have short half-lives, making their utility as potential…”
    Get full text
    Journal Article
  7. 7

    RTI-263, a biased neuropeptide S receptor agonist that retains an anxiolytic effect, attenuates cocaine-seeking behavior in rats by Huang, Yuanli, Wojciechowski, Alaina, Feldman, Kyle, Ettaro, Robert, Veros, Kaliana, Ritter, Morgan, Costa, Paula, DiStasio, Jacob, Peirick, Jennifer J., Reissner, Kathryn J., Runyon, Scott P., Clark, Stewart D.

    Published in Neuropharmacology (15-12-2023)
    “…Neuropeptide S (NPS) is a neuromodulatory peptide that acts via a G protein-coupled receptor. Centrally administered NPS suppresses anxiety-like behaviors in…”
    Get full text
    Journal Article
  8. 8

    Blocking Alcoholic Steatosis in Mice with a Peripherally Restricted Purine Antagonist of the Type 1 Cannabinoid Receptor by Amato, George S, Manke, Amruta, Harris, Danni L, Wiethe, Robert W, Vasukuttan, Vineetha, Snyder, Rodney W, Lefever, Timothy W, Cortes, Ricardo, Zhang, Yanan, Wang, Shaobin, Runyon, Scott P, Maitra, Rangan

    Published in Journal of medicinal chemistry (24-05-2018)
    “…Type 1 cannabinoid receptor (CB1) antagonists have demonstrated promise for the treatment of obesity, liver disease, metabolic syndrome, and dyslipidemias…”
    Get full text
    Journal Article
  9. 9

    Identifying structural determinants of potency for analogs of apelin-13: Integration of C-terminal truncation with structure–activity by Zhang, Yanyan, Maitra, Rangan, Harris, Danni L., Dhungana, Suraj, Snyder, Rodney, Runyon, Scott P.

    Published in Bioorganic & medicinal chemistry (01-06-2014)
    “…Apelin peptides function as endogenous ligands of the APJ receptor and have been implicated in a number of important biological processes. While several…”
    Get full text
    Journal Article
  10. 10

    Preclinical Efficacy and Selectivity of Vaccines Targeting Fentanyl, Alfentanil, Sufentanil, and Acetylfentanyl in Rats by Baehr, Carly, Robinson, Christine, Kassick, Andrew, Jahan, Rajwana, Gradinati, Valeria, Averick, Saadyah E., Runyon, Scott P., Pravetoni, Marco

    Published in ACS omega (17-05-2022)
    “…The ongoing public health emergency of opioid use disorders (OUD) and overdose in the United States is largely driven by fentanyl and its related analogues and…”
    Get full text
    Journal Article
  11. 11

    Discovery of a novel small molecule agonist scaffold for the APJ receptor by Narayanan, Sanju, Maitra, Rangan, Deschamps, Jeffery R., Bortoff, Katherine, Thomas, James B., Zhang, Yanyan, Warner, Keith, Vasukuttan, Vineetha, Decker, Ann, Runyon, Scott P.

    Published in Bioorganic & medicinal chemistry (15-08-2016)
    “…[Display omitted] The apelinergic system includes a series of endogenous peptides apelin, ELABELA/TODDLER and their 7-transmembrane G-protein coupled apelin…”
    Get full text
    Journal Article
  12. 12

    Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulation by Clark, Stewart D., Kenakin, Terrence P., Gertz, Steven, Hassler, Carla, Gay, Elaine A., Langston, Tiffany L., Reinscheid, Rainer K., Runyon, Scott P.

    Published in Neuropharmacology (15-05-2017)
    “…The neuropeptide S system has been implicated in a number of centrally mediated behaviors including memory consolidation, anxiolysis, and increased locomotor…”
    Get full text
    Journal Article
  13. 13

    Anti-Müllerian hormone as a biomarker for acute testicular degeneration caused by toxic insults to stallion testes by Pozor, Malgorzata, Conley, Alan J., Roser, Janet F., Nolin, Maggie, Zambrano, Gina L., Runyon, Scott P., Kelleman, Audrey A., Macpherson, Margo L.

    Published in Theriogenology (01-08-2018)
    “…Recently, anti-Müllerian hormone (AMH) was validated as a reliable marker of testicular damage caused by various chemotherapy drugs in humans and in mice. In…”
    Get full text
    Journal Article
  14. 14

    Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery: Miniperspective by Narayanan, Sanju, Harris, Danni L, Maitra, Rangan, Runyon, Scott P

    Published in Journal of medicinal chemistry (22-10-2015)
    “…Apelin peptides and the apelin receptor represent a relatively new therapeutic axis for the potential treatment of cardiovascular disease. Several reports…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Synthesis and pharmacological characterization of functionalized 6-piperazin-1-yl-purines as cannabinoid receptor 1 (CB1) inverse agonists by Amato, George S., Manke, Amruta, Vasukuttan, Vineetha, Wiethe, Robert W., Snyder, Rodney W., Runyon, Scott P., Maitra, Rangan

    Published in Bioorganic & medicinal chemistry (15-08-2018)
    “…[Display omitted] Antagonists of peripheral type 1 cannabinoid receptors (CB1) may have utility in the treatment of obesity, liver disease, metabolic syndrome…”
    Get full text
    Journal Article
  17. 17

    Antagonism of the neuropeptide S receptor with RTI-118 decreases cocaine self-administration and cocaine-seeking behavior in rats by Schmoutz, Christopher D., Zhang, Yanan, Runyon, Scott P., Goeders, Nicholas E.

    Published in Pharmacology, biochemistry and behavior (01-12-2012)
    “…Neuropeptide S (NPS) is a neuromodulatory peptide, acting via a G-protein-coupled receptor to regulate sleep, anxiety and behavioral arousal. Recent research…”
    Get full text
    Journal Article
  18. 18

    Effects of inhibitory GABA-active neurosteroids on cocaine seeking and cocaine taking in rats by Schmoutz, Christopher D., Runyon, Scott P, Goeders, Nicholas E.

    Published in Psychopharmacology (01-09-2014)
    “…Rationale Several compounds that potentiate GABA-induced inhibitory currents also decrease stress, anxiety and addiction-related behaviors. Because of the…”
    Get full text
    Journal Article
  19. 19

    A therapeutic combination of metyrapone and oxazepam increases brain levels of GABA-active neurosteroids and decreases cocaine self-administration in male rats by Schmoutz, Christopher D., Guerin, Glenn F., Runyon, Scott P., Dhungana, Suraj, Goeders, Nicholas E.

    Published in Behavioural brain research (15-09-2015)
    “…•Combination of metyrapone and oxazepam (MET/OX) decreases drug self-administration.•MET/OX treatment increases neurosteroid levels in rat brain…”
    Get full text
    Journal Article
  20. 20